Omniceutics Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 29-10-2024
- Paid Up Capital ₹ 0.10 M
as on 29-10-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 29-10-2024
- Revenue %
(FY 2023)
- Profit 2753.32%
(FY 2023)
- Ebitda 1955.30%
(FY 2023)
- Net Worth 3467.93%
(FY 2023)
- Total Assets 14148.60%
(FY 2023)
About Omniceutics Healthcare
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Sarada Gudipati and Dronamraju Prabhu serve as directors at the Company.
- CIN/LLPIN
U51391TG2021PTC154156
- Company No.
154156
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2021
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Omniceutics Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarada Gudipati  | Director | 17-Aug-2021 | Current |
| Dronamraju Prabhu | Director | 17-Aug-2021 | Current |
Financial Performance of Omniceutics Healthcare.
Omniceutics Healthcare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 2753.32% increase in profit. The company's net worth Soared by an impressive increase of 3467.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omniceutics Healthcare?
In 2023, Omniceutics Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aeternitas Pharmaceuticals Private LimitedActive 6 years 3 monthsSarada Gudipati and Dronamraju Prabhu are mutual person
- Trisun Innovations Private LimitedActive 4 years 3 months
Sarada Gudipati and Dronamraju Prabhu are mutual person
- Trisun Holdings Private LimitedActive 4 years 4 months
Sarada Gudipati and Dronamraju Prabhu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 Apr 2024 | ₹1.00 Cr | Open |
How Many Employees Work at Omniceutics Healthcare?
Omniceutics Healthcare has a workforce of 46 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omniceutics Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omniceutics Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
